LeMaitre Vascular, Inc.

$81.91

+$1.74 (+2.17%)

Jan 5, 2026

Price History (1Y)

Analysis

LeMaitre Vascular, Inc. is a healthcare company operating in the medical instruments and supplies industry. The company has a market capitalization of $1.86 billion, revenue of $240.87 million (TTM), and employs 651 people. The company's financial health indicates strong profitability, with gross margins at 71.0%, operating margin at 25.4%, and profit margin at 22.1%. Additionally, the return on equity is 15.0% and the return on assets is 7.9%. The balance sheet shows a debt to equity ratio of 48.99 and a current ratio of 13.58. LeMaitre Vascular also has $343.06 million in cash and $185.63 million in debt. The company's valuation context can be assessed through its price-to-earnings (P/E) ratios, which are 35.31 (TTM) and 31.65 (forward). The revenue growth rate is 11.4% year-over-year, while the earnings growth rate is 53.6%. LeMaitre Vascular has a dividend yield of 100.0%, with a payout ratio of 32.8%.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature, as well as human cadaver tissue cryopreservation services. It also provides a suite of biologic products comprising artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches used for vessel closure after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular and porcine patches; carotid shunts that temporarily shunt the blood to the brain; biosynthetic vascular grafts indicated for lower extremity bypass and dialysis access; phlebectomy system for resection and ablation of varicose veins; LifeSpan vascular grafts, which are expanded polytetrafluoroethylene grafts; and vascular grafts used to bypass or replace diseased arteries. In addition, the company offers radiopaque tape, a medical-grade tape; valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Visit website →

Key Statistics

Market Cap
$1.86B
P/E Ratio
35.31
52-Week High
$105.55
52-Week Low
$71.42
Avg Volume
163.70K
Beta
0.67
Dividend Yield
100.00%

Company Info

Exchange
NGM
Country
United States
Employees
651